CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade DBV Technologies SA - DBV CFD

    1.21
    1.63%
    0.07
    Low: 1.21
    High: 1.26
    Market Trading Hours* (UTC) Open now
    Closes on Friday at 15:30

    Mon - Fri: 07:00 - 15:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.022102 %
    Charges from full value of position ($-4.20)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.022102%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000121 %
    Charges from full value of position ($-0.02)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000121%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 5%
    Stock exchange France
    Commission on trade 0%

    *Information provided by Capital.com

    Dbv Technologies SA ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 1.23
    Open* 1.23
    1-Year Change* -58.02%
    Day's Range* 1.21 - 1.26
    52 wk Range 1.38-4.30
    Average Volume (10 days) 95.83K
    Average Volume (3 months) 4.08M
    Market Cap 164.04M
    P/E Ratio -100.00K
    Shares Outstanding 96.10M
    Revenue 4.83M
    EPS -0.99
    Dividend (Yield %) N/A
    Beta 0.88
    Next Earnings Date Feb 29, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 18, 2024 1.23 0.01 0.82% 1.22 1.24 1.22
    Apr 17, 2024 1.22 0.00 0.00% 1.22 1.26 1.22
    Apr 16, 2024 1.23 -0.01 -0.81% 1.24 1.27 1.23
    Apr 15, 2024 1.26 0.02 1.61% 1.24 1.29 1.24
    Apr 12, 2024 1.22 -0.01 -0.81% 1.23 1.26 1.22
    Apr 11, 2024 1.23 -0.05 -3.91% 1.28 1.31 1.23
    Apr 10, 2024 1.30 0.00 0.00% 1.30 1.32 1.28
    Apr 9, 2024 1.32 -0.01 -0.75% 1.33 1.34 1.31
    Apr 8, 2024 1.33 0.00 0.00% 1.33 1.35 1.31
    Apr 5, 2024 1.35 0.01 0.75% 1.34 1.38 1.34
    Apr 4, 2024 1.36 0.04 3.03% 1.32 1.36 1.32
    Apr 3, 2024 1.32 0.02 1.54% 1.30 1.34 1.30
    Apr 2, 2024 1.32 -0.02 -1.49% 1.34 1.34 1.30
    Mar 28, 2024 1.29 0.02 1.57% 1.27 1.31 1.27
    Mar 27, 2024 1.30 0.00 0.00% 1.30 1.32 1.28
    Mar 26, 2024 1.32 0.03 2.33% 1.29 1.32 1.28
    Mar 25, 2024 1.31 0.01 0.77% 1.30 1.32 1.28
    Mar 22, 2024 1.29 -0.02 -1.53% 1.31 1.32 1.26
    Mar 21, 2024 1.31 -0.01 -0.76% 1.32 1.34 1.29
    Mar 20, 2024 1.33 0.03 2.31% 1.30 1.34 1.30

    DBV Technologies SA Events

    Time (UTC) Country Event
    Monday, July 29, 2024

    Time (UTC)

    10:59

    Country

    FR

    Event

    Half Year 2024 Dbv Technologies SA Earnings Release
    Half Year 2024 Dbv Technologies SA Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 4.844 5.708 11.276 14.708 15.9805
    Revenue 4.844 5.708 11.276 14.708 15.9805
    Cost of Revenue, Total 0.778 0.519 0.272 1.089 1.7325
    Gross Profit 4.066 5.189 11.004 13.619 14.248
    Total Operating Expense 101.037 103.972 169.224 185.055 198.686
    Selling/General/Admin. Expenses, Total 24.527 33.499 43.509 69.211 80.2214
    Research & Development 61.069 57.993 81.105 107.92 112.102
    Depreciation / Amortization 14.663 12.881 21.344 6.835 4.63025
    Operating Income -96.193 -98.264 -157.948 -170.347 -182.706
    Interest Income (Expense), Net Non-Operating 0.255 -0.169 -1.727 -1.512 0.156101
    Net Income Before Taxes -95.938 -98.433 -159.675 -171.859 -182.551
    Net Income After Taxes -96.008 -98.052 -159.665 -172.469 -182.567
    Net Income Before Extra. Items -96.008 -98.052 -159.665 -172.469 -182.567
    Net Income -96.008 -98.052 -159.665 -172.469 -182.567
    Income Available to Common Excl. Extra. Items -96.008 -98.052 -159.665 -172.469 -182.567
    Income Available to Common Incl. Extra. Items -96.008 -98.052 -159.665 -172.469 -182.567
    Diluted Net Income -96.008 -98.052 -159.665 -172.469 -182.567
    Diluted Weighted Average Shares 77.3841 54.9169 54.0927 37.0073 28.925
    Diluted EPS Excluding Extraordinary Items -1.24067 -1.78546 -2.95169 -4.66041 -6.31175
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -1.24067 -1.79635 -2.67539 -4.66041 -6.31175
    Other Operating Expenses, Total
    Other, Net -0.001099
    Unusual Expense (Income) 0 -0.92 22.994 0
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total revenue 4.482 0.77 4.074 4.255 1.453
    Revenue 4.482 0.77 4.074 4.255 1.453
    Total Operating Expense 50.742 56.702 44.335 41.942 62.03
    Selling/General/Admin. Expenses, Total 12.271 15.72 9.414 21.147 12.471
    Research & Development 29.913 36.058 25.182 27.597 30.796
    Unusual Expense (Income) 0 -0.92
    Operating Income -46.26 -55.932 -40.261 -37.687 -60.577
    Interest Income (Expense), Net Non-Operating 1.398 -0.572 0.827 -0.101 -0.068
    Net Income Before Taxes -44.862 -56.504 -39.434 -37.788 -60.645
    Net Income After Taxes -44.875 -56.487 -39.521 -37.811 -60.241
    Net Income Before Extra. Items -44.875 -56.487 -39.521 -37.811 -60.241
    Net Income -44.875 -56.487 -39.521 -37.811 -60.241
    Income Available to Common Excl. Extra. Items -44.875 -56.486 -39.522 -37.812 -60.24
    Income Available to Common Incl. Extra. Items -44.875 -56.486 -39.522 -37.812 -60.24
    Diluted Net Income -44.875 -56.486 -39.522 -37.812 -60.24
    Diluted Weighted Average Shares 94.1501 94.2782 60.4901 54.9411 54.8928
    Diluted EPS Excluding Extraordinary Items -0.47663 -0.59914 -0.65336 -0.68823 -1.09741
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.47663 -0.59914 -0.65336 -0.69911 -1.09741
    Other Operating Expenses, Total -3.557 -0.001 -6.204 0.001
    Total Adjustments to Net Income 0.001 -0.001 -0.001 0.001
    Depreciation / Amortization 8.558 8.481 9.74 0.322 18.762
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 223.108 114.516 207.374 204.554 159.913
    Cash and Short Term Investments 209.194 77.301 196.352 193.255 134.961
    Cash 30.104 31.427 42.341 57.882 84.9055
    Cash & Equivalents 179.09 45.874 154.011 135.373 50.0555
    Total Receivables, Net 11.235 33.066 7.86 5.415 18.5408
    Accounts Receivable - Trade, Net 0 2.23 0
    Total Inventory 2.289 1.7215
    Prepaid Expenses 2.68 4.149 3.162 3.596 4.68851
    Total Assets 246.494 146.323 272.019 271.273 188.804
    Property/Plant/Equipment, Total - Net 17.552 24.917 34.669 48.148 22.2267
    Property/Plant/Equipment, Total - Gross 32.34 38.716 51.359 59.249 29.9317
    Accumulated Depreciation, Total -14.788 -13.799 -16.69 -11.101 -7.70499
    Intangibles, Net 0.01 0.022 0.041 0.048 0.03188
    Long Term Investments 5.824 6.868 29.935 18.523 6.63207
    Total Current Liabilities 29.521 31.398 52.713 53.999 47.8668
    Accounts Payable 14.473 11.429 20.338 24.004 31.4037
    Accrued Expenses 5.941 6.89 17.241 20.764 7.46534
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 7.213 10.076 11.426 5.545 8.99777
    Total Liabilities 51.997 47.294 66.631 78.539 55.474
    Total Long Term Debt 1.15 7.147 10.496 21.995 0
    Other Liabilities, Total 21.326 8.749 3.422 2.545 7.60715
    Total Equity 194.497 99.029 205.388 192.734 133.33
    Common Stock 10.72 6.538 6.518 5.645 3.31549
    Additional Paid-In Capital 294.881 199.801 996.849 847.274 592.844
    Retained Earnings (Accumulated Deficit) -96.594 -101.239 -804.209 -643.239 -462.829
    Other Equity, Total -14.51 -6.071 6.23 -16.946
    Total Liabilities & Shareholders’ Equity 246.494 146.323 272.019 271.273 188.804
    Total Common Shares Outstanding 93.9874 54.9493 54.8787 46.9918 30.1166
    Other Current Assets, Total -0.001 -0.001 0.001099
    Other Long Term Assets, Total
    Current Port. of LT Debt/Capital Leases 1.894 3.003 3.708 3.686
    Capital Lease Obligations 1.15 7.147 10.496 21.995
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total Current Assets 195.54 223.108 260.088 114.516
    Cash and Short Term Investments 173.961 209.194 247.971 77.301
    Cash 24.111 30.104 226.674 31.427
    Cash & Equivalents 149.85 179.09 21.297 45.874
    Total Receivables, Net 17.084 11.235 11.02 33.066
    Total Inventory
    Prepaid Expenses 4.494 2.68 1.097 4.149
    Other Current Assets, Total 0.001 -0.001
    Total Assets 217.478 246.494 284.922 146.323
    Property/Plant/Equipment, Total - Net 15.927 17.552 18.597 24.917
    Property/Plant/Equipment, Total - Gross 32.34 38.716
    Accumulated Depreciation, Total -14.788 -13.799
    Intangibles, Net 0.068 0.01 0.014 0.022
    Long Term Investments 5.944 5.824 6.223 6.868
    Total Current Liabilities 33.373 29.521 30.431 31.398
    Accounts Payable 19.094 14.473 16.341 11.429
    Accrued Expenses 4.561 5.941 4.535 6.89
    Notes Payable/Short Term Debt 0 0 0 0
    Current Port. of LT Debt/Capital Leases 1.944 1.894 1.967 3.003
    Other Current Liabilities, Total 7.774 7.213 7.588 10.076
    Total Liabilities 53.18 51.997 40.501 47.294
    Total Long Term Debt 0.187 1.15 1.972 7.147
    Capital Lease Obligations 0.187 1.15 1.972 7.147
    Other Liabilities, Total 19.62 21.326 8.098 8.749
    Total Equity 164.298 194.497 244.421 99.029
    Common Stock 10.952 10.72 10.708 6.538
    Additional Paid-In Capital 208.974 294.881 295.693 199.801
    Retained Earnings (Accumulated Deficit) -44.564 -96.594 -42.574 -101.239
    Other Equity, Total -11.064 -14.51 -19.406 -6.071
    Total Liabilities & Shareholders’ Equity 217.478 246.494 284.922 146.323
    Total Common Shares Outstanding 96.1012 93.9874 54.9493 54.9493
    Accounts Receivable - Trade, Net 0
    Other Long Term Assets, Total -0.001
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -159.374 -172.469 -175.276 -155.875
    Cash From Operating Activities -160.892 -143.885 -144.19 -120.647
    Cash From Operating Activities 15.783 6.381 2.98678 3.08809
    Non-Cash Items 0.151 18.762 28.444 32.8661
    Changes in Working Capital -17.452 3.441 -0.34406 -0.726114
    Cash From Investing Activities -2.865 -5.662 -9.11969 -8.26799
    Capital Expenditures -2.761 -5.597 -5.01419 -7.96298
    Other Investing Cash Flow Items, Total -0.104 -0.065 -4.1055 -0.30501
    Cash From Financing Activities 144.837 203.116 137.915 0.301844
    Financing Cash Flow Items -1.34 -2.495 -2.05169 -0.580469
    Issuance (Retirement) of Stock, Net 149.886 208.938 139.967 0.882313
    Foreign Exchange Effects 22.017 -0.886 -0.554084 3.4501
    Net Change in Cash 3.097 52.683 -15.9481 -125.163
    Cash Interest Paid 1.002 1.135
    Issuance (Retirement) of Debt, Net -3.709 -3.327
    Dec 2021 Jun 2021 Dec 2020 Jun 2020
    Net income/Starting Line -159.374 -91.3383
    Cash From Operating Activities -160.892 -83.8345
    Cash From Operating Activities 15.783 16.4399
    Non-Cash Items 0.151 3.15036
    Cash Interest Paid 1.002 0.491815
    Changes in Working Capital -17.452 -12.0864
    Cash From Investing Activities -2.865 -1.38785
    Capital Expenditures -2.761 -1.37202
    Other Investing Cash Flow Items, Total -0.104 -0.015831
    Cash From Financing Activities 144.837 141.672
    Financing Cash Flow Items -1.34 -0.492871
    Issuance (Retirement) of Stock, Net 149.886 143.877
    Issuance (Retirement) of Debt, Net -3.709 -1.71186
    Foreign Exchange Effects 22.017 0.365168
    Net Change in Cash 3.097 56.8152

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    DBV Technologies Company profile

    About DBV Technologies SA

    DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, DBV Technologies SA revenues decreased 49% to $5.7M. Net loss applicable to common stockholders decreased 39% to $98.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and Development decrease of 31% to $70.1M (expense), Restructuring decrease from $23M (expense) to $920K (income).

    Industry: Proprietary & Advanced Pharmaceuticals

    177-181 avenue Pierre Brossolette
    MONTROUGE
    ILE-DE-FRANCE 92120
    FR

    Income Statement

    • Annual
    • Quarterly

    News

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    A way forward: a roundup of recent central bank decisions

    Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

    12:47, 22 March 2024

    Bank of Japan Preview: will the BOJ end negative interest rates?

    The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

    08:44, 18 March 2024

    People also watch

    Gold

    2,389.89 Price
    +0.350% 1D Chg, %
    Long position overnight fee -0.0190%
    Short position overnight fee 0.0108%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    XRP/USD

    0.50 Price
    -1.060% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    BTC/USD

    64,297.45 Price
    +1.240% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    US100

    17,205.50 Price
    -0.770% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading